No Data
No Data
Morgan Stanley Initiates ROHTO PHARMACEUTICAL CO(RPHCF.US) With Buy Rating, Announces Target Price $27.98
J.P. Morgan Maintains ROHTO PHARMACEUTICAL CO(RPHCF.US) With Buy Rating, Cuts Target Price to $24
Nomura Maintains ROHTO PHARMACEUTICAL CO(RPHCF.US) With Buy Rating, Cuts Target Price to $24.68
Jefferies Initiates ROHTO PHARMACEUTICAL CO(RPHCF.US) With Sell Rating, Announces Target Price $15.8
Nomura Initiates ROHTO PHARMACEUTICAL CO(RPHCF.US) With Buy Rating, Announces Target Price $32.53
ROHTO PHARMACEUTICAL CO To Go Ex-Dividend On September 27th, 2024 With 0.1408 USD Dividend Per Share
No Data